Literature DB >> 20104482

Induced tolerance to rat liver allografts involves the apoptosis of intragraft T cells and the generation of CD4(+)CD25(+)FoxP3(+) T regulatory cells.

Masato Fujiki1, Carlos O Esquivel, Olivia M Martinez, Samuel Strober, Shinji Uemoto, Sheri M Krams.   

Abstract

Posttransplant total lymphoid irradiation is a nonmyeloablative regimen that has been extensively studied in rodent models for the induction of tolerance to bone marrow and solid organ allografts. Previous studies of experimental models and clinical transplantation have used total lymphoid irradiation in combination with anti-lymphocyte-depleting reagents and donor cell infusion to promote graft acceptance. In a rat model of orthotopic liver transplantation, we demonstrated that total lymphoid irradiation alone induced long-term graft survival. Apoptotic T cells were detected in markedly higher numbers in the livers of the total lymphoid irradiation-treated group in comparison with the control group of liver allograft recipients. Intragraft CD4(+)CD25(+)FoxP3(+) cells were increased in the total lymphoid irradiation group in the first week post-transplant and remained elevated in the graft and in the spleen. Importantly, the adoptive transfer of splenocytes from recipients that received posttransplant total lymphoid irradiation prolonged the survival of donor heart grafts, but not third-party heart grafts, whereas the depletion of CD4(+)CD25(+) cells from transferred splenocytes abrogated this prolongation. We conclude that posttransplant total lymphoid irradiation significantly increases the apoptosis of T cells in the liver graft and allows the accumulation of CD4(+)CD25(+)FoxP3(+) T regulatory cells, which facilitate the generation of donor-specific tolerance.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20104482      PMCID: PMC2937179          DOI: 10.1002/lt.21963

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  33 in total

1.  Liver transplants induce deletion of liver-specific T cells.

Authors:  S Celli; P Matzinger
Journal:  Transplant Proc       Date:  2001 Feb-Mar       Impact factor: 1.066

2.  Evidence that apoptosis of activated T cells occurs in spontaneous tolerance of liver allografts and is blocked by manipulations which break tolerance.

Authors:  A Sharland; Y Yan; C Wang; D G Bowen; J Sun; A G Sheil; G W McCaughan; G A Bishop
Journal:  Transplantation       Date:  1999-12-15       Impact factor: 4.939

Review 3.  The liver as a site of T-cell apoptosis: graveyard, or killing field?

Authors:  I N Crispe; T Dao; K Klugewitz; W Z Mehal; D P Metz
Journal:  Immunol Rev       Date:  2000-04       Impact factor: 12.988

Review 4.  Mixed chimerism and transplant tolerance.

Authors:  M Sykes
Journal:  Immunity       Date:  2001-04       Impact factor: 31.745

5.  Clinical transplantation tolerance twelve years after prospective withdrawal of immunosuppressive drugs: studies of chimerism and anti-donor reactivity.

Authors:  S Strober; C Benike; S Krishnaswamy; E G Engleman; F C Grumet
Journal:  Transplantation       Date:  2000-04-27       Impact factor: 4.939

6.  Comparison of chimeric acid and non-chimeric tolerance using posttransplant total lymphoid irradiation: cytokine expression and chronic rejection.

Authors:  K Hayamizu; F Lan; P Huie; R K Sibley; S Strober
Journal:  Transplantation       Date:  1999-10-15       Impact factor: 4.939

7.  Liver allografts are toleragenic in rats conditioned with posttransplant total lymphoid irradiation.

Authors:  Kazuhito Nagasaki; Hideaki Obara; Anming Xiong; Neeraja Kambham; Samuel Strober; Carlos O Esquivel; Maria T Millan
Journal:  Transplantation       Date:  2007-09-15       Impact factor: 4.939

8.  Tolerance and chimerism after renal and hematopoietic-cell transplantation.

Authors:  John D Scandling; Stephan Busque; Sussan Dejbakhsh-Jones; Claudia Benike; Maria T Millan; Judith A Shizuru; Richard T Hoppe; Robert Lowsky; Edgar G Engleman; Samuel Strober
Journal:  N Engl J Med       Date:  2008-01-24       Impact factor: 91.245

9.  Decreases in circulating CD4+CD25hiFOXP3+ cells and increases in intragraft FOXP3+ cells accompany allograft rejection in pediatric liver allograft recipients.

Authors:  Fabien Stenard; Christine Nguyen; Ken Cox; Neeraja Kambham; Dale T Umetsu; Sheri M Krams; Carlos O Esquivel; Olivia M Martinez
Journal:  Pediatr Transplant       Date:  2008-03-10

10.  Rapamycin, but not cyclosporine or FK506, alters natural killer cell function.

Authors:  Lu-En Wai; Masato Fujiki; Saori Takeda; Olivia M Martinez; Sheri M Krams
Journal:  Transplantation       Date:  2008-01-15       Impact factor: 4.939

View more
  9 in total

1.  Apoptotic cell administration enhances pancreatic islet engraftment by induction of regulatory T cells and tolerogenic dendritic cells.

Authors:  Cong Wu; Yi Zhang; Yingming Jiang; Quanxing Wang; Yao Long; Chunmei Wang; Xuetao Cao; Guoyou Chen
Journal:  Cell Mol Immunol       Date:  2013-07-22       Impact factor: 11.530

Review 2.  Differential expression and functions of microRNAs in liver transplantation and potential use as non-invasive biomarkers.

Authors:  Liang Wei; Xue Gong; Olivia M Martinez; Sheri M Krams
Journal:  Transpl Immunol       Date:  2013-08-31       Impact factor: 1.708

3.  Delayed and short course of rapamycin prevents organ rejection after allogeneic liver transplantation in rats.

Authors:  Salim Hamdani; Allan Thiolat; Sina Naserian; Cynthia Grondin; Stéphane Moutereau; Anne Hulin; Julien Calderaro; Philippe Grimbert; José Laurent Cohen; Daniel Azoulay; Caroline Pilon
Journal:  World J Gastroenterol       Date:  2017-10-14       Impact factor: 5.742

4.  Identification of the rat NKG2D ligands, RAE1L and RRLT, and their role in allograft rejection.

Authors:  Ming Zhuo; Masato Fujiki; Mouer Wang; Karine Piard-Ruster; Lu-En Wai; Liang Wei; Olivia M Martinez; Sheri M Krams
Journal:  Eur J Immunol       Date:  2010-06       Impact factor: 5.532

5.  Prediction of tumor recurrence by distinct immunoprofiles in liver transplant patients based on mass cytometry.

Authors:  Xuyong Wei; Wentao Xie; Weiwei Yin; Mengfan Yang; Abdul Rehman Khan; Renyi Su; Wenzhi Shu; Binhua Pan; Guanghan Fan; Kun Wang; Fan Yang; Di Lu; Changbiao Li; Linhui Pan; Beini Cen; Haiyang Xie; Li Zhuang; Shusen Zheng; Xun Zeng; Wei Chen; Xiao Xu
Journal:  Am J Cancer Res       Date:  2022-09-15       Impact factor: 5.942

6.  Liver microRNA Profile of Induced Allograft Tolerance.

Authors:  Matthew James Vitalone; Liang Wei; Masato Fujiki; Audrey H Lau; Erik Littau; Carlos Esquivel; Olivia M Martinez; Sheri M Krams
Journal:  Transplantation       Date:  2016-04       Impact factor: 4.939

7.  Serial Monitoring of Immune Markers Being Represented Regulatory T Cell/T Helper 17 Cell Ratio: Indicating Tolerance for Tapering Immunosuppression after Liver Transplantation.

Authors:  JooYeon Jhun; Seung Hoon Lee; Soon Kyu Lee; Hee Yeon Kim; Eun Sun Jung; Dong Goo Kim; JeongWon Choi; Si Hyun Bae; Seung Kew Yoon; Byung Ha Chung; Chul Woo Yang; Mi-La Cho; Jong Young Choi
Journal:  Front Immunol       Date:  2018-03-01       Impact factor: 7.561

Review 8.  Progress in Liver Transplant Tolerance and Tolerance-Inducing Cellular Therapies.

Authors:  Xiaoxiao Du; Sheng Chang; Wenzhi Guo; Shuijun Zhang; Zhonghua Klaus Chen
Journal:  Front Immunol       Date:  2020-06-24       Impact factor: 7.561

Review 9.  Regulatory T-Cell Therapy in Liver Transplantation and Chronic Liver Disease.

Authors:  Angus Hann; Ye H Oo; M Thamara P R Perera
Journal:  Front Immunol       Date:  2021-10-14       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.